ARGONAUT THERAPEUTICS Trademark

Trademark Overview


On Friday, July 24, 2020, a trademark application was filed for ARGONAUT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ARGONAUT THERAPEUTICS trademark a serial number of 90072154. The federal status of this trademark filing is REGISTERED as of Tuesday, December 28, 2021. This trademark is owned by Argonaut Therapeutics Limited. The ARGONAUT THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer

Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research a...
argonaut therapeutics

General Information


Serial Number90072154
Word MarkARGONAUT THERAPEUTICS
Filing DateFriday, July 24, 2020
Status700 - REGISTERED
Status DateTuesday, December 28, 2021
Registration Number6600091
Registration DateTuesday, December 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2021

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesEpigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer
Goods and ServicesResearch and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArgonaut Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressOxford OX44GA
GB

Party NameArgonaut Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOxford OX44GA
GB

Party NameArgonaut Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOxford OX44GA
GB

Trademark Events


Event DateEvent Description
Tuesday, December 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 3, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 3, 2021EXAMINER'S AMENDMENT ENTERED
Friday, September 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 3, 2021EXAMINERS AMENDMENT E-MAILED
Friday, September 3, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, August 12, 2021ASSIGNED TO EXAMINER
Wednesday, July 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 7, 2021ASSIGNED TO LIE
Monday, May 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, November 17, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 28, 2020NEW APPLICATION ENTERED IN TRAM